Leyson, Baby Boy .
HRN: 25-38-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2024
AMPICILLIN 1GM (VIAL)
07/02/2024
07/09/2024
INTRAVENOUS
170 Mg IVTT
Every 12 Hours
Unspecified Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes